Topics

Ceapro using patented technology to disrupt the natural health care products sector

08:43 EDT 2 May 2019 | Proactive Investors

Ceapro Inc (CVE:CZO) President & CEO Gilles Gagnon spoke with Christine Corrado from Proactive Investors at the ThinkEquity Conference in New York. The Canadian biotech company is involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and “active ingredients” from oats and other renewable plant resources. 

Original Article: Ceapro using patented technology to disrupt the natural health care products sector

NEXT ARTICLE

More From BioPortfolio on "Ceapro using patented technology to disrupt the natural health care products sector"

Quick Search

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...